Q32 Bio | 424B3: Prospectus
Q32 Bio | 424B3: Prospectus
Q32 Bio | 424B3: Prospectus
Q32 Bio | EFFECT: Others
Q32 Bio | 424B3: Prospectus
Homology Medicines | 424B3: Prospectus
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | EFFECT: Others
Homology Medicines | 424B3: Prospectus
Homology Medicines | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Homology Medicines | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Homology Medicines | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | S-4: Registration of securities issued in business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Homology Medicines | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
No Data
No Data